0001237899-12-000102.txt : 20121218 0001237899-12-000102.hdr.sgml : 20121218 20121218113109 ACCESSION NUMBER: 0001237899-12-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121214 FILED AS OF DATE: 20121218 DATE AS OF CHANGE: 20121218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCorkle Douglas S CENTRAL INDEX KEY: 0001403178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 121270449 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-12-14 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001403178 McCorkle Douglas S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Controller & Asst Treasurer Common Stock 2012-12-17 4 M 0 4000.0 16.8 A 4000.0 D Common Stock 2012-12-17 4 M 0 800.0 16.8 A 4800.0 D Common Stock 2012-12-17 4 S 0 800.0 179.45 D 4000.0 D Common Stock 2012-12-17 4 M 0 200.0 16.8 A 4200.0 D Common Stock 2012-12-17 4 S 0 200.0 178.19 D 4000.0 D Common Stock 4008.0 I By 401(k) Plan Incentive Stock Option (right to buy) 16.8 2012-12-17 4 M 0 4000.0 D 2018-12-17 Common Stock 4000.0 1000.0 D Incentive Stock Option (right to buy) 16.8 2012-12-17 4 M 0 800.0 D 2018-12-17 Common Stock 800.0 200.0 D Incentive Stock Option (right to buy) 16.8 2012-12-17 4 M 0 200.0 D 2018-12-17 Common Stock 200.0 0.0 D Non-Qualified Stock Option (right to buy) 179.13 2012-12-14 4 A 0 26000.0 A 2022-12-14 Common Stock 26000.0 26000.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 800 shares of Company stock on December 17, 2012 at prices ranging from $179.02 to $179.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2012 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on December 17, 2012 at prices ranging from $178.06 to $178.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 17, 2012 at each separate price. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Douglas McCorkle 2012-12-18